4.6 Article

Cognitive performance of breast cancer survivors in daily life: Role of fatigue and depressed mood

期刊

PSYCHO-ONCOLOGY
卷 28, 期 11, 页码 2174-2180

出版社

WILEY
DOI: 10.1002/pon.5203

关键词

breast cancer; cognition; depression; ecological momentary assessment; fatigue; memory; oncology; survivorship; quality of life

资金

  1. American Cancer Society
  2. National Cancer Institute [R03 CA191712]

向作者/读者索取更多资源

Objective Cancer and its treatment are associated with long-term cognitive deficits. However, most studies of cancer patients have used traditional, office-based cognitive evaluations instead of assessing patients in their daily lives. Recent research in cognitive aging suggests that variability in performance may be a sensitive indicator of cognitive decline. Using ecological momentary assessment (EMA), we examined cognitive variability among breast cancer survivors and evaluated whether ratings of fatigue and depressed mood were associated with cognition. Methods Participants were 47 women (M age = 53.3 years) who completed treatment for early stage breast cancer 6 to 36 months previously. Smartphones were preloaded with cognitive tests measuring processing speed, executive functioning, and memory, as well as rating scales for fatigue and depressed mood. Participants were prompted five times per day over a 14-day period to complete EMA cognitive tasks and fatigue and depressed mood ratings. Results Cognitive variability was observed across all three EMA cognitive tasks. Processing speed responses were slower at times that women rated themselves as more fatigued than their average (P < .001). Ratings of depressed mood were not associated with cognition. Conclusions This study is the first to report cognitive variability in the daily lives of women treated for breast cancer. Performance was worse on a measure of processing speed at times when a woman rated her fatigue as greater than her own average. The ability to identify moments when cognition is most vulnerable may allow for personalized interventions to be applied at times when they are most needed.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

Elevated C-Reactive Protein and Subsequent Patient-Reported Cognitive Problems in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study

Judith E. Carroll, Zev M. Nakamura, Brent J. Small, Xingtao Zhou, Harvey J. Cohen, Tim A. Ahles, Jaeil Ahn, Traci N. Bethea, Martine Extermann, Deena Graham, Claudine Isaacs, Heather S. L. Jim, Paul B. Jacobsen, Brenna C. McDonald, Sunita K. Patel, Kelly Rentscher, James Root, Andrew J. Saykin, Danielle B. Tometich, Kathleen Van Dyk, Wanting Zhai, Elizabeth C. Breen, Jeanne S. Mandelblatt

Summary: The study examined the longitudinal relationships between levels of C-reactive protein (CRP) and cognition in older breast cancer survivors and noncancer controls. The results showed that breast cancer survivors had higher levels of CRP, and increased CRP levels predicted lower cognitive function. This suggests that chronic inflammation may play a role in the development of cognitive problems.

JOURNAL OF CLINICAL ONCOLOGY (2023)

Article Oncology

Premature aging as an accumulation of deficits in young adult survivors of pediatric cancer

AnnaLynn M. Williams, Jeanne Mandelblatt, Mingjuan Wang, Gregory T. Armstrong, Nickhill Bhakta, Tara M. Brinkman, Wassim Chemaitilly, Matthew J. Ehrhardt, Daniel A. Mulrooney, Brent J. Small, Zhaoming Wang, Deokumar Srivastava, Leslie L. Robison, Melissa M. Hudson, Kirsten K. Ness, Kevin R. Krull

Summary: This study aimed to compare the accumulation of deficits in survivors of pediatric cancer with community controls and examine associations with host and treatment factors, neurocognition, and mortality. The results showed that pediatric cancer survivors experience clinically significant premature aging, with a DAI score of 0.16 at age 30 corresponding to age 63 in controls (33 years premature aging). Higher DAI scores were associated with increased risk of neurocognitive impairment and death.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Cognition in patients treated with targeted therapy for chronic myeloid leukemia: a controlled comparison

Kelly A. Hyland, Sarah L. Eisel, Aasha I. Hoogland, James C. Root, Kris Bowles, Brian James, Ashley M. Nelson, Margaret Booth-Jones, Paul B. Jacobsen, Tim A. Ahles, Heather S. L. Jim, Brian D. Gonzalez

Summary: This controlled comparison study evaluated the cognitive function and symptoms of patients with chronic myeloid leukemia receiving tyrosine kinase inhibitors. The study found that patients had worse overall neuropsychological performance and verbal memory compared to controls. Patients also reported greater fatigue, insomnia, and depressive symptoms, which were associated with worse subjective cognition.

LEUKEMIA & LYMPHOMA (2023)

Article Oncology

Diet quality indices and changes in cognition during chemotherapy

Sylvia L. Crowder, Taylor L. Welniak, Aasha I. Hoogland, Brent J. Small, Yvelise Rodriguez, Kristen M. Carpenter, Stacy M. Fischer, Daneng Li, Anita Y. Kinney, Daniel Rotroff, Arshiya Mariam, Naomi Brownstein, Richard R. Reich, Tim Hembree, Mary C. Playdon, Anna E. Arthur, Christian AMaino Vieytes, Zonggui Li, Martine Extermann, Richard Kim, Donna L. Berry, Heather S. L. Jim

Summary: This study aimed to evaluate the association between pre-treatment diet quality indices and changes in cognitive function. The study found that a higher ratio of monounsaturated to saturated fat intake was associated with less decline in cognitive function 5 days after infusion. This suggests that consuming more monounsaturated fat and less saturated fat may have a protective effect against cancer-related cognitive decline during chemotherapy.

SUPPORTIVE CARE IN CANCER (2023)

Article Psychology, Multidisciplinary

An Examination of the Longitudinal Relationship Between Cognitive Function and Physical Activity Among Older Breast Cancer Survivors in the Thinking and Living With Cancer Study

Danielle B. Tometich, Catherine E. Mosher, Melissa Cyders, Brenna C. McDonald, Andrew J. Saykin, Brent J. Small, Zhai Wanting, Zhou Xingtao, Heather S. L. Jim, Paul Jacobsen, Tim A. Ahles, James C. Root, Deena Graham, Sunita K. Patel, Jeanne Mandelblatt

Summary: Physical activity may improve cognitive function for older cancer survivors, and cognitive function may also affect the ability to organize oneself to be physically active. However, the expected prospective relationships between cognition and physical activity were not found in this study. The findings indicate that there is cross-sectional association between cognition and physical activity in survivors, but long-term predictive relationships were not observed. The study suggests that future research should consider the impact of cognitive function when older cancer survivors are attempting to increase their physical activity.

ANNALS OF BEHAVIORAL MEDICINE (2023)

Review Biochemistry & Molecular Biology

Gut microbiome and cancer implications: Potential opportunities for fermented foods

Sylvia L. Crowder, Heather S. L. Jim, Stephanie Hogue, Tiffany L. Carson, Doratha A. Byrd

Summary: There is a critical opportunity to improve cancer treatment outcomes and enhance anti-cancer immunity through dietary interventions aimed at modifying the gut microbiome with fermented foods. This review summarizes the current literature on the gut microbiome and response to immunotherapy and other cancer treatments, discusses the potential clinical implications of utilizing a fermented foods dietary approach, and highlights existing gaps in the literature regarding fermented food interventions in cancer patients. The review provides a compelling rationale for future research on fermented food dietary interventions for modulating the gut microbiome to reduce cancer burden.

BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2023)

Article Oncology

Epigenetic aging in older breast cancer survivors and non-cancer controls: preliminary findings from the Thinking and Living with Cancer (TLC) Study

Kelly E. Rentscher, Traci N. Bethea, Wanting Zhai, Brent J. Small, Xingtao Zhou, Tim A. Ahles, Jaeil Ahn, Elizabeth C. Breen, Harvey Jay Cohen, Martine Extermann, Deena M. A. Graham, Heather S. L. Jim, Brenna C. McDonald, Zev M. Nakamura, Sunita K. Patel, James C. Root, Andrew J. Saykin, Kathleen Van Dyk, Jeanne S. Mandelblatt, Judith E. Carroll

Summary: This study aimed to investigate if older breast cancer survivors had higher levels of epigenetic aging and if it was related to functional outcomes. The study found that breast cancer survivors had higher levels of epigenetic aging compared to non-cancer controls, especially those who had undergone chemotherapy. Additionally, epigenetic aging was associated with worse cognitive and physical function.

CANCER (2023)

Article Oncology

Plasma levels of interleukin-6 mediate neurocognitive performance in older breast cancer survivors: The Thinking and Living With Cancer study

Jeanne S. Mandelblatt, Brent J. Small, Xingtao Zhou, Zev M. Nakamura, Harvey J. Cohen, Tim A. Ahles, Jaeil Ahn, Traci N. Bethea, Martine Extermann, Deena Graham, Claudine Isaacs, Paul B. Jacobsen, Heather S. L. Jim, Brenna C. McDonald, Sunita K. Patel, Kelly E. Rentscher, James C. Root, Andrew J. Saykin, Danielle B. Tometich, Kathleen Van Dyk, Wanting Zhai, Elizabeth C. Breen, Judith E. Carroll

Summary: Immune activation/inflammation markers were found to explain differences in neurocognition between breast cancer survivors and noncancer controls. Breast cancer survivors had significantly higher IL-6 levels before and after systemic therapy, and IL-6 partially explained the neurocognitive differences between survivors and controls.

CANCER (2023)

Article Oncology

Genetic Variants Associated with Longitudinal Cognitive Performance in Older Breast Cancer Patients and Controls †

Kelly Nudelman, Kwangsik Nho, Michael Zhang, Brenna C. McDonald, Wanting Zhai, Brent J. Small, Claire E. Wegel, Paul B. Jacobsen, Heather S. L. Jim, Sunita K. Patel, Deena M. A. Graham, Tim A. Ahles, James C. Root, Tatiana Foroud, Elizabeth C. Breen, Judith E. Carroll, Jeanne S. Mandelblatt, Andrew J. Saykin

Summary: This study found that genetics may play an important role in modifying risk for cognitive decline in older female breast cancer survivors. Several genetic variants and genes were identified to be associated with differences in patterns of cognitive decline in cancer patients compared to controls. Further research and validation of these findings in other cancer populations is necessary to inform therapeutic research and evaluations of risk for cognitive decline in older cancer survivors.

CANCERS (2023)

Review Oncology

Social isolation and social connectedness among young adult cancer survivors: A systematic review

Rina S. S. Fox, Grace E. E. Armstrong, Julia S. S. Gaumond, Taylor F. D. Vigoureux, Corinne H. H. Miller, Stacy D. D. Sanford, John M. M. Salsman, Emmanuel Katsanis, Terry A. A. Badger, Damon R. R. Reed, Brian D. D. Gonzalez, Heather S. L. Jim, Echo L. L. Warner, David E. E. Victorson, Laura B. B. Oswald

Summary: This review evaluated the prevalence, correlates, and psychosocial implications of social isolation and connectedness among young adult cancer survivors aged 18-39 years. The results showed that social isolation was similarly prevalent among young adults, older cancer survivors, and noncancer populations. Social isolation was related to worse psychological well-being, whereas social connectedness was often, but not always, related to better psychological well-being.

CANCER (2023)

Article Oncology

Examining disparities in large-scale patient-reported data capture using digital tools among cancer patients at clinical intake

Dana E. Rollison, Brian D. Gonzalez, Kea Turner, Heather S. L. Jim, Yayi Zhao, Rossybelle P. Amorrortu, Rachel Howard, Kavita M. Ghia, Bryan Ngo, Phillip Reisman, Colin Moore, Randa Perkins, Robert J. Keenan, David A. Sallman, Cristina M. Naso, Edmondo J. Robinson, Susan T. Vadaparampil, Vani N. Simmons, Matthew B. Schabath, Scott M. Gilbert

Summary: Patient-reported data can improve healthcare quality and patient outcomes. This study investigated the completion rates of an Electronic Patient Questionnaire (EPQ) used to collect demographics, sexual orientation, and gender identity data, and found associations with demographic and cancer characteristics. The findings are important for improving data acquisition methods and identifying potential disparities in data completeness that may impact clinical care quality and generalizability of self-reported data.

CANCER MEDICINE (2023)

Article Oncology

Relationships among Inflammatory Biomarkers and Self-Reported Treatment-Related Symptoms in Patients Treated with Chemotherapy for Gynecologic Cancer: A Controlled Comparison

Aasha I. Hoogland, Brent J. Small, Laura B. Oswald, Crystal Bryant, Yvelise Rodriguez, Brian D. Gonzalez, Xiaoyin Li, Michelle C. Janelsins, Hailey W. Bulls, Brian W. James, Bianca Arboleda, Claudia Colon-Echevarria, Mary K. Townsend, Shelley S. Tworoger, Paulo C. Rodriguez, Julienne E. Bower, Sachin M. Apte, Robert M. Wenham, Heather S. L. Jim

Summary: Treatment-related symptoms such as fatigue, depression, and disruptions in sleep and physical activity are common in gynecologic cancer patients. Higher levels of inflammation, particularly C-reactive protein, are associated with worse symptomatology, specifically depression and disrupted physical activity. However, inflammation may not be significantly related to fatigue or sleep disturbance.

CANCERS (2023)

Meeting Abstract Oncology

Black-White differences in physical and cognitive aging among older breast cancer survivors in the Thinking and Living with Cancer Study

Traci N. Bethea, Wanting Zhai, Xingtao Zhou, Tim A. Ahles, Jaeil Ahn, Harvey J. Cohen, Asma A. Dilawari, Deena Graham, Heather Jim, Brenna C. McDonald, Zev M. Nakamura, Sunita K. Patel, Kelly E. Rentscher, James C. Root, Andrew J. Saykin, Brent J. Small, Kathleen Van Dyk, Jeanne S. Mandelblatt, Judith E. Carroll

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Article Oncology

A dyadic examination of patients' and caregivers' attachment orientations and mutually supportive care in cancer caregiving

Christine J. McPherson, Alanna Devereaux

Summary: This study examines the dyadic effects of patient and caregiver attachment orientations on mutually supportive care in cancer treatment. It highlights the interdependence within the cancer caregiving relationship and emphasizes the importance of considering individual and relational ways of responding in providing support. Attachment theory provides a framework for understanding and therapeutic intervention.

PSYCHO-ONCOLOGY (2024)